MAR 25, 2019 09:04 AM PDT

Aspirin Combats Tuberculosis

WRITTEN BY: Nouran Amin

Tuberculosis is a global infection far from being eradicated. It currently infects more than 1,400 people per year in Australia. The deadliest form and expensive to treat is antibiotic resistant tuberculosis—costing about $250,000 to treat a single case.

Now, researchers at the Centenary Institute have been working on new treatments for tuberculosis by seeking to increase the effectiveness of the immune system. In particular, they found a brand new target for the treatment of drug-resistant tuberculosis. Through their understanding that the tuberculosis bacterium alters platelets from the body's blood clotting system to weaken the immune systems—scientists were able to use a zebrafish model of tuberculosis to observe the build-up of clots and activation of platelets on infected regions, using fluorescent microscopy.

"The zebrafish gives us literal insight into disease processes by watching cells interacting in real time,” says senior author and head of the Centenary's Immune-Vascular Interactions laboratory, Dr. Stefan Oehlers.

 

 

Green platelets sticking to red blood vessels next to sites of infection by blue bacteria. Pathogenic platelets are the green cells that stick next to the bacteria for a few minutes.

According to the study published in The Journal of Infectious Diseases, the platelets were found to be tricked by the infection by getting in to the way of the body's defense system. Therefore, they treated the sites of infection with anti-platelet drugs, including the most common form of aspirin. The aspirin was found to prevent the altercations of platelets and allowed the body to control the infection better.

"This is the first time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant TB,” says Dr. Elinor Hortle, lead author of the paper. "Our study provides more crucial evidence that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives.”

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Preventive Drug Decreases Cases of Leprosy in Morocco
Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect ...
JAN 23, 2019
Cardiology
JAN 23, 2019
New Discoveries Bring Us Closer To Eliminating Heart Attacks
A host of new discoveries bring medicine closer to the goal of ending heart attacks. These include new protective methods that can help identify those at r...
FEB 25, 2019
Drug Discovery
FEB 25, 2019
ADHD Drug Holds No Effect on Primate Prefrontal Cortex
According to a new research study published eNeuro, investigations of methylphenidate (Ritalin) on neuronal activity in monkeys held no effects on the pref...
MAR 01, 2019
Drug Discovery
MAR 01, 2019
Nicotine on Human Embryonic Development
Researchers report in a study published in the journal Stem Cell Reports, that nicotine exerted adverse effects on human embryonic development at the cellu...
MAR 19, 2019
Health & Medicine
MAR 19, 2019
Can a Low-Carb Diet Treat Osteoarthritis?
A pilot study suggests it might. Researchers at the University of Alabama, Birmingham, found that a low-carbohydrate diet was able to reduce pain intensity...
MAR 31, 2019
Drug Discovery
MAR 31, 2019
Chemopreventative Drug Targets H. Pylori Infections
A chemopreventative drug being tested for its ability to inhibit the production of cell growth in multiple types of cancer was found to act directly on the...
Loading Comments...